Table 1.
Comparison of glioma patients and controls by characteristics.
| Characteristics | Glioma patients (N = 568) | Healthy controls (N = 509) | P |
|---|---|---|---|
| Age | 39.68 ± 16.96 | 41.32 ± 15.69 | 0.102 |
| >40 | 296(52%) | 241(47%) | |
| ≤40 | 272(48%) | 268(53%) | |
| Sex | 1.000 | ||
| Male | 313(55%) | 280(55%) | |
| Female | 255(45%) | 229(45%) | |
| Astrocytoma | |||
| Yes | 438(77%) | ||
| No | 130 (23%) | ||
| WHO grade | |||
| I | 35(6%) | ||
| II | 320(56%) | ||
| III | 149(26%) | ||
| IV | 64(12%) | ||
| Surgery | |||
| STR & NTR | 181 (32%) | ||
| GTR | 387 (68%) | ||
| Radiotherapy | |||
| No | 59 (10%) | ||
| Conformable radiotherapy | 154 (27%) | ||
| Gamma knife | 355 (63%) | ||
| Chemotherapy | |||
| No | 337 (59%) | ||
| Yes-temodar | 49 (9%) | ||
| Yes-not temodar | 182 (32%) | ||
WHO, World Health Organization; STR, sub-total resection; NTR, near-total resection; GTR, gross-total resection.